The short answer
A low egg count reflects how many follicles grew that cycle: partly ovarian reserve, partly age, sometimes the dose. In 400,135 UK cycles, live birth rose with egg number up to about 15 5. Fewer eggs lowers the odds per cycle without ending them, and ESHRE's 2025 guideline does not recommend DHEA to raise the count 1.
Your egg collection happened, but the number was smaller than you were hoping for, or smaller than your doctor predicted. Perhaps it was two or three eggs from a cycle that cost as much as one that produces fifteen. It is natural to read that number as a verdict on your fertility.
It is more useful as information. Doctors sort low responses into groups, using the 2011 Bologna criteria and the newer POSEIDON groups, because the reason for a low count and the outlook differ a lot between them 2,3. This page explains those groups in plain language so you can see which one you are likely in, what the evidence says about egg number and live birth, and what ESHRE's 2025 stimulation guideline says is worth changing next time 1.
How common is this?
9
Median number of eggs per fresh IVF cycle in the UK, 1991–2008 (400,135 cycles)5
about 47%
Share of IVF patients who fall into one of the four POSEIDON low-prognosis groups, as estimated by POSEIDON authors3
64%
Women under 41 with an unexpected poor first response who responded normally in their second cycle (Utrecht, 161 women)8
31%
Same measure for women with an expected poor response (aged 41 or over, or raised FSH; 64 women)8
about 15
Egg number at which live birth per fresh cycle stopped rising in UK data; it plateaued between 15 and 205
Reading your report
- AFC (antral follicle count)
- The number of small follicles seen on a scan early in the cycle. It estimates how many follicles can respond to stimulation.
- AMH
- Anti-Müllerian hormone, a blood test. ESHRE recommends AMH or AFC to predict how many eggs stimulation will produce, but not to predict pregnancy 1.
- Low responder (formerly 'poor responder')
- Someone whose ovaries produce fewer follicles and eggs than usual under stimulation. ESHRE's 2025 guideline replaced 'poor' with 'low' to avoid implying a prognosis 1.
- Bologna criteria
- ESHRE's 2011 definition of poor ovarian response 2. See the explanation below.
- POSEIDON groups 1–4
- A 2016 system that sorts 'low-prognosis' patients by age, ovarian reserve and, if known, the number of eggs from a previous cycle 3,4.
- Starting dose (IU)
- The daily dose of FSH injections, in international units. ESHRE treats 150–225 IU as the conventional dose 1.
- Cumulative live birth or delivery rate
- The chance of at least one baby from all the embryos made in one egg collection, fresh and frozen transfers together.
Likely causes, most common first
| Cause | How you'd know | Test that tells you |
|---|---|---|
| Low ovarian reserve (an expected low response) | Low AMH or AFC before the cycle; POSEIDON groups 3 and 4 3 | AMH or AFC, the tests ESHRE recommends for predicting response 1 |
| Age | ESHRE lists female age as a predictor of pregnancy and live birth 1; age mainly affects the share of eggs with the right number of chromosomes 4 | None; age shapes how the count is interpreted 4 |
| The dose or protocol did not suit your ovaries (an unexpected low response) | Normal AMH or AFC but fewer than 10 eggs; POSEIDON groups 1 and 2 3 | Stimulation chart review with your doctor 9 |
| Early ovulation before collection | A rise in LH before the trigger; more common with low ovarian reserve in one Indian study 12 | LH results from the last monitoring days 12 |
What did not cause this
"I should have taken DHEA or supplements beforehand"
ESHRE's 2025 guideline does not recommend DHEA for low responders and says myo-inositol is not recommended for them either 1. ESHRE's add-ons recommendations do not recommend antioxidants in IVF 11.
"Few eggs means my eggs are poor quality"
Egg number and egg quality are different things. POSEIDON's authors describe the age-related fall in egg quality as largely due to chromosome errors, which is why the groups split by age 4. A younger woman with few eggs has a different outlook from an older woman with the same count 7.
"One bad response means every cycle will be like this"
In a Dutch study, 64% of women with an unexpected poor response responded normally the next time, most of them on a higher dose 8.
What counts as a low egg count?
There is no single number. The 2011 Bologna criteria, from an ESHRE working group, call a response 'poor' when at least two of three features are present: age 40 or over (or another risk factor), a previous poor response of 3 eggs or fewer or a cancelled cycle, and an abnormal ovarian reserve test (AFC below 5–7 or AMH below 0.5–1.1 ng/ml) 2,3. Two poor responses after maximal stimulation are enough on their own 2.
The Bologna definition grouped very different women together. By 2016, more than 70 randomised trials in poor responders had used a wide range of definitions, and no single treatment had been shown to help them 4. That is why the POSEIDON group proposed a more detailed system 4.
Which POSEIDON group am I in?
POSEIDON asks three questions: how old you are, what your ovarian reserve tests showed before treatment, and, if you have had a stimulated cycle, how many eggs were collected 3,4. The age line is 35. The reserve line is an AFC of 5, or an AMH of 1.2 ng/ml 3.
- Group 1: under 35, normal reserve (AFC 5 or more, or AMH 1.2 or more), but fewer than 10 eggs. 1a is fewer than 4 eggs; 1b is 4 to 9 3.
- Group 2: 35 or over, normal reserve, but fewer than 10 eggs. 2a is fewer than 4; 2b is 4 to 9 3.
- Group 3: under 35 with low reserve (AFC under 5, or AMH under 1.2) 3.
- Group 4: 35 or over with low reserve 3.
- Groups 1 and 2 are 'unexpected' low responses: the tests predicted more eggs. Groups 3 and 4 are 'expected' ones 3.
Does the number of eggs affect my chance of a baby?
Yes, but the relationship is not linear. In 400,135 UK cycles, live birth per fresh cycle rose with each extra egg up to about 15, levelled off between 15 and 20, and fell beyond 20 5. With 15 eggs in 2006–2007, predicted live birth was 40% at 18–34, 36% at 35–37, 27% at 38–39 and 16% at 40 and over 5.
Counting frozen embryos as well changes the picture. In 14,469 first cycles, cumulative live birth kept rising with egg number and reached 70% with 25 or more eggs 6.
Age matters as much as number. In POSEIDON's worked example, with typical lab rates, a 36-year-old needs about 12 eggs for one chromosomally normal blastocyst 4. That is an estimate from assumed rates, not a promise for any one woman.
The table below shows how often one egg collection led to a baby in each POSEIDON group, in 9,073 first cycles in Brazil, Turkey and Vietnam 7. Among the unexpected low responders, those with 4–9 eggs had about twice the rate of those with fewer than 4 7.
Will my next cycle go the same way?
Not necessarily, especially if the low count was unexpected. In the Utrecht study, 64% of unexpected poor responders and 31% of expected poor responders responded normally in their second cycle, most of them on a higher dose 8. After three cycles, the cumulative ongoing pregnancy rate was 37–47% for the unexpected group and 16–19% for the expected group 8.
For women with a suboptimal first response (4–9 eggs), a study of 160 second cycles found the median rose from 6 to 9 eggs 9. There, the only factor that predicted more eggs was a higher starting dose, with about one extra egg per 50 IU 9.
A higher dose does not help when reserve itself is low. In a randomised trial of women with an AFC under 5, doubling the starting dose from 150 to 300 IU gave a median of 3 eggs in both groups 10. ESHRE's 2025 guideline does not recommend doses above 300 IU for predicted low responders 1. It also says changing the dose partway through stimulation is probably not useful, so getting the starting dose right matters 1.
What does ESHRE's 2025 guideline say about protocols and add-ons for low responders?
ESHRE's 2025 update contains 121 recommendations, and none rests on high-quality evidence 1. For low responders, most options it reviewed showed no clear benefit. ESHRE also says a low response on its own is not a reason to cancel a cycle 1.
- Adding LH (r-hLH) to FSH: no better than FSH alone for low responders (probably equally recommended) 1.
- Letrozole added to injections: probably not recommended. Clomiphene with or without injections: probably equal to injections alone 1.
- Modified natural cycle: probably not routinely recommended, though clinicians could choose it for very low reserve 1.
- Double stimulation (two stimulations in one menstrual cycle): can be used to build up eggs or embryos when no fresh transfer is planned 1. ESHRE's 2023 add-ons paper had not recommended it for routine use 11.
- Dual trigger (agonist plus hCG): probably not recommended for low responders 1.
- Not recommended: DHEA, aspirin, sildenafil and myo-inositol. Probably not recommended: testosterone and growth hormone 1.
- Injecting platelet-rich plasma (PRP) into the ovaries: not recommended by ESHRE, as no randomised trials had been published 11.
It depends on…
Chance of at least one baby from one egg collection, by POSEIDON group. 9,073 women aged 22–42 in their first IVF cycle, Brazil, Turkey and Vietnam, 2015–2017; groups defined by AFC
| Group | Who | Cumulative delivery rate per collection |
|---|---|---|
| 1a | Under 35, normal reserve, fewer than 4 eggs | 27.8% 7 |
| 1b | Under 35, normal reserve, 4–9 eggs | 47.8% 7 |
| 2a | 35 or over, normal reserve, fewer than 4 eggs | 14.0% 7 |
| 2b | 35 or over, normal reserve, 4–9 eggs | 30.5% 7 |
| 3 | Under 35, low reserve (AFC under 5) | 29.4% 7 |
| 4 | 35 or over, low reserve (AFC under 5) | 12.5% 7 |
| Not POSEIDON | Normal reserve and 10 or more eggs | 50.6% 7 |
What's worth checking
- Write down your AMH or AFC from before the cycle, and your age at egg collection.
- Note the number of eggs collected and how many were mature.
- Use the list above to work out your likely POSEIDON group, then check it with your doctor.
- Ask for your starting dose, any dose changes, and the protocol name.
- Check the last LH results for any sign of early ovulation.
- Ask how many embryos were made and frozen from this collection.
- Before paying for any supplement or add-on, ask for its ESHRE 2025 rating.
What could change next cycle
9 options, by strength of evidence
- Mixed, or some groups only 3
- Not enough studies yet 2
- Evidence says it doesn't help 4
Ratings follow the evidence reviews cited beside each option, not our opinion.
- Changing the starting dose after an unexpected low or suboptimal responseMixed, or some groups only
ESHRE stresses getting the starting dose right 1; one observational study saw about 1 more egg per extra 50 IU 9.
- Starting dose above 300 IU with low reserveEvidence says it doesn't help
ESHRE 2025: not recommended 1; doubling to 300 IU did not raise the count in an RCT 10.
- Double stimulation to build up embryos over one menstrual cycleMixed, or some groups only
ESHRE 2025: can be used when no fresh transfer is planned 1.
- Modified natural cycleMixed, or some groups only
ESHRE 2025: not routinely, but an option in very low reserve 1.
- Adding LH, letrozole or a dual triggerEvidence says it doesn't help
ESHRE 2025: no advantage for low responders 1.
- DHEAEvidence says it doesn't help
ESHRE 2025: not recommended for low responders (strong recommendation) 1.
- Testosterone or growth hormoneEvidence says it doesn't help
ESHRE 2025: probably not recommended for low responders 1.
- Ovarian PRP injectionNot enough studies yet
ESHRE add-ons 2023: not recommended; no randomised trials 11.
- Antioxidants such as CoQ10Not enough studies yet
ESHRE add-ons 2023: not recommended in IVF; evidence very low quality 11.
Questions to ask your doctor
- Which POSEIDON group do you think I am in, and why?
- Was my low count expected from my AMH and AFC, or was it a surprise?
- Would you change my starting dose or protocol, and what do you expect that to change?
- Given my age and egg count, what is my realistic chance per collection, and how many collections would you plan?
- Would banking embryos over more than one collection make sense for me?
- If you are suggesting any supplement or add-on, what is its ESHRE 2025 rating?
Questions people ask
Is 5 eggs enough for IVF?
Can I improve my egg count with diet or supplements?
Why did my doctor say not to cancel even though only two follicles grew?
Is the Bologna or the POSEIDON classification better?
Why did I have 12 follicles on the scan but only 5 eggs?
Not every follicle holds an egg that can be collected. The ESHRE-Alpha laboratory consensus expects 80-95% of the follicles measured on trigger day to yield an egg in a stimulated cycle, and treats a result outside that range as a reason to review stimulation, triggering and aspiration practice 13. POSEIDON researchers call an egg count below half the antral follicle count a hypo-response 3.
Is 3 eggs enough for IVF?
It can be, and your age counts for more than the number. In 9,073 first cycles, women under 35 with fewer than 4 eggs had a 27.8% chance of a baby from that one collection, fresh and frozen transfers together, against 14.0% for women aged 35 and over 7. Fewer eggs is not the same as worse eggs: POSEIDON splits its groups by age because chromosome errors rise with age 4.
Only 3 of my 6 eggs were mature. Is that normal?
It is below the expected share. The ESHRE-Alpha consensus expects 75-90% of the eggs collected to be mature when they are assessed for ICSI, about 40 hours after the trigger 13. Only mature eggs can be injected, so the mature count, rather than the total collected, is the number that sets how many can be fertilised 13.
I only have one ovary. Does that halve my egg count?
Not halve. In a Mayo Clinic cohort of 51 women with one ovary and a comparison group with both, the single ovary produced more follicles and more eggs than one ovary of a two-ovary woman, although the overall total was still lower; live birth rates were similar in the two groups 14. Markers of ovarian reserve did not differ 14.
Can the immature eggs be matured in the lab?
It is possible but not recommended as routine. In a study of 440 low responders summarised by ESHRE, injecting immature eggs that matured in culture alongside the mature ones gave a similar clinical pregnancy rate (16.5% versus 16.7%) and more embryos to transfer 11. ESHRE's 2023 add-ons group does not recommend rescue in vitro maturation for routine clinical use, citing unestablished effectiveness and safety 11.
Will acupuncture or herbal medicine increase my egg count?
There is no evidence that they do. ESHRE's 2023 add-ons group does not recommend acupuncture, Chinese and herbal medicine, or other complementary therapies in fertility treatment 11. The trials it reviewed measured pregnancy and birth rather than egg numbers, and in one meta-analysis of four randomised trials, acupuncture around the time of transfer made no difference to live birth 11.
Why did my doctor expect more eggs than I got?
Because prediction is imperfect. ESHRE recommends AMH or antral follicle count for predicting response, and recommends against using age, body mass index or basal FSH for it 1. When the ovaries deliver less than the tests predicted, POSEIDON researchers list possible reasons: differences in the FSH and LH receptors, a dose that was too low, follicles growing out of step, and technical problems with the trigger or the collection 3.
Does my weight affect how many eggs I get?
ESHRE's 2025 guideline does not recommend body mass index for predicting ovarian response, so it is not used to forecast egg numbers 1. The same guideline does list female age and body mass index as predictors of pregnancy and live birth 1. That is a pattern across large groups of women, not a forecast for one cycle.
Sources
- ESHRE Guideline Group on Ovarian Stimulation; Ata B, Bosch E, Broer S, Griesinger G, Grynberg M, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025. Hum Reprod. 2026;41(4):498-514. ESHRE / Human Reproduction
- Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616-1624. ESHRE / Human Reproduction
- Roque M, Haahr T, Esteves SC, Humaidan P. The POSEIDON stratification: moving from poor ovarian response to low prognosis. JBRA Assist Reprod. 2021;25(2):282-292. JBRA Assisted Reproduction
- Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome. F1000Res. 2016;5:2911. F1000Research (POSEIDON group)
- Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26(7):1768-1774. Human Reproduction
- Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ~15,000 women. Fertil Steril. 2018;110(4):661-670.e1. Fertility and Sterility
- Esteves SC, Yarali H, Vuong LN, Carvalho JF, Özbek İY, Polat M, et al. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients. Hum Reprod. 2021;36(8):2157-2169. Human Reproduction
- Klinkert ER, Broekmans FJ, Looman CW, te Velde ER. A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertil Steril. 2004;81(5):1247-1253. Fertility and Sterility
- Drakopoulos P, Santos-Ribeiro S, Bosch E, Garcia-Velasco J, Blockeel C, Romito A, et al. The effect of dose adjustments in a subsequent cycle of women with suboptimal response following conventional ovarian stimulation. Front Endocrinol (Lausanne). 2018;9:361. Frontiers in Endocrinology
- Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod. 2005;20(3):611-615. Human Reproduction
- ESHRE Add-ons Working Group; Lundin K, Bentzen JG, Bozdag G, Ebner T, Harper J, et al. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38(11):2062-2104. ESHRE / Human Reproduction
- Kochhar PK, Ghosh P. Diminished ovarian reserve predisposes to premature luteinizing hormone surges in gonadotropin-releasing hormone antagonist cycles in in vitro fertilization. J Hum Reprod Sci. 2020;13(3):191-195. Journal of Human Reproductive Sciences (India)
- ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine. The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators. Hum Reprod Open. 2017;2017(2):hox011. ESHRE / ALPHA / Human Reproduction Open
- Khan Z, Gada RP, Tabbaa ZM, Laughlin-Tommaso SK, Jensen JR, Coddington CC 3rd, Stewart EA. Unilateral oophorectomy results in compensatory follicular recruitment in the remaining ovary at time of ovarian stimulation for in vitro fertilization. Fertil Steril. 2014;101(3):722-727. Fertility and Sterility
- Human Fertilisation and Embryology Authority. Risks of fertility treatment. HFEA patient information. HFEA
- NHS. IVF. nhs.uk tests and treatments. Last reviewed 15 April 2025. NHS (nhs.uk)
- American Society for Reproductive Medicine. Assisted Reproductive Technologies: a patient education booklet. Revised 2018. ASRM / ReproductiveFacts.org
- Levi-Setti PE, Cirillo F, Scolaro V, Morenghi E, Heilbron F, Girardello D, Zannoni E, Patrizio P. Appraisal of clinical complications after 23,827 oocyte retrievals in a large assisted reproductive technology program. Fertil Steril. 2018;109(6):1038-1043.e1. Fertility and Sterility